Suchergebnisse - "Nilsson, Monique B"

PubPharm (23)

1

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers : Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Udagawa, H. | Nilsson, M. | Robichaux, J. | +15

2

IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Patel, S. | Nilsson, M. | Yang, Y. | +14

3

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

enthalten in: Cancer cell | 2023

von Nilsson, M. | Yang, Y. | Heeke, S. | +24

4

Poziotinib for EGFR exon 20-mutant NSCLC : Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

enthalten in: Cancer cell | 2022

von Elamin, Y. | Robichaux, J. | Carter, B. | +24

CommentIn: Cancer Cell. 2022 Jul 11;40(7):705-708. - PMID 35820394

5

Structure-based classification predicts drug response in EGFR-mutant NSCLC

enthalten in: Nature | 2021

von Robichaux, J. | Le, X. | Vijayan, R. | +30

CommentIn: Cancer Cell. 2021 Nov 8;39(11):1455-1457. - PMID 34752753

6

ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC

enthalten in: Cancer cell | 2021

von Le, X. | Nilsson, M. | Robichaux, J. | +1

CommentOn: Cancer Cell. 2021 Sep 13;39(9):1279-1291.e3. - PMID 34388377

7

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC : Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Nilsson, M. | Robichaux, J. | Herynk, M. | +19

8

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

enthalten in: Science translational medicine | 2020

von Nilsson, M. | Sun, H. | Robichaux, J. | +21

9

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

enthalten in: Cancer cell | 2019

von Robichaux, J. | Elamin, Y. | Vijayan, R. | +28

ErratumIn: Cancer Cell. 2020 Mar 16;37(3):420. - PMID 32183953

10

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Le, X. | Puri, S. | Negrao, M. | +21

CommentIn: Clin Cancer Res. 2018 Dec 15;24(24):6112-6114. - PMID 30352903